According to Enzo Biochem's latest financial reports and stock price the company's current number of shares outstanding is 50,490,000. At the end of 2024 the company had 50,490,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 50.49 M | 0.61% |
2023 | 50.18 M | 3% |
2022 | 48.72 M | 0.51% |
2021 | 48.47 M | 1.2% |
2020 | 47.89 M | 0.71% |
2019 | 47.55 M | 0.79% |
2018 | 47.18 M | 0.58% |
2017 | 46.91 M | 1.39% |
2016 | 46.27 M | 0.44% |
2015 | 46.06 M | 3.37% |
2014 | 44.56 M | 8.54% |
2013 | 41.05 M | 4.53% |
2012 | 39.27 M | 1.77% |
2011 | 38.59 M | 1.15% |
2010 | 38.16 M | 0.81% |
2009 | 37.85 M | 1.39% |
2008 | 37.33 M | 1.69% |
2007 | 36.71 M | 13.75% |
2006 | 32.27 M | 0.38% |
2005 | 32.15 M | -0.8% |
2004 | 32.41 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Quest Diagnostics
DGX | 112,000,000 | 121.83% | ๐บ๐ธ USA |
LabCorp LH | 84,900,000 | 68.15% | ๐บ๐ธ USA |
RadNet RDNT | 67,793,404 | 34.27% | ๐บ๐ธ USA |
Psychemedics PMD | 5,755,000 | -88.60% | ๐บ๐ธ USA |
NeoGenomics
NEO | 125,687,000 | 148.93% | ๐บ๐ธ USA |
Qiagen QGEN | 221,356,672 | 338.42% | ๐ณ๐ฑ Netherlands |